wr 1065 has been researched along with Esophageal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Ghissassi, F; Hainaut, P; Maurici, D; North, S; Pluquet, O | 1 |
1 other study(ies) available for wr 1065 and Esophageal Neoplasms
Article | Year |
---|---|
Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1.
Topics: Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytoprotection; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Esophageal Neoplasms; Genes, p53; Humans; Mercaptoethylamines; Mutation; Protein Conformation; Radiation-Protective Agents; RNA, Neoplasm; Temperature; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |